Notice of Intent to Sole Source Nucleic Acid Testing (NAT) Analyzers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA) has issued a Notice of Intent to Sole Source for the lease of Nucleic Acid Testing (NAT) Analyzers for the Medical Treatment Facility (MTF) and Blood Donor Center at JBSA Lackland, Texas. This acquisition is for the Grifols Procleix Panther system, identified as the only source capable of meeting all requirements. This notice is a Justification and Approval (J&A) for a sole-source acquisition, with no open competition at this time.
Purpose
The primary purpose is to acquire three (3) Nucleic Acid Testing Analyzers and associated support services to screen blood and plasma donations for infectious diseases, including West Nile Virus (WNV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Babesia. This supports the medical processing of approximately 30,000 Basic Military Trainees annually and the collection of 10,000 blood units.
Scope of Work
- Lease of three (3) new Nucleic Acid Testing Analyzers.
- Continuous equipment lease and support services, including preventative maintenance, unscheduled repairs, and software revisions.
- Equipment must be capable of simultaneous testing for WNV, HBV, HCV, HIV, and Babesia.
- Throughput requirement: 275 results in 8 hours or 500 results in 24 hours.
- Compact physical footprint (must fit within a 238 sq ft space) with capacity for two analyzers for redundancy.
- Must not require a water treatment system and be compatible with existing laboratory utilities.
- Provision of a full uninterruptable power supply (UPS).
- Installation by company engineers, initial validation, and calibration.
- Onsite and offsite training for MTF personnel.
- Maintenance: Seven (7) days a week, 24-hour hotline support with on-site service within 24 hours if phone support fails.
- Bi-directional interface for the hospital Electronic Health Record (EHR) system.
- Contractor personnel must comply with MTF infection control, safety, HIPAA, and Privacy Act regulations.
Contract Details
- Contract Type: Firm-Fixed Price (FFP).
- Period of Performance: 12 months (Base Period: May 29, 2026 – May 28, 2027).
- Funding Type: Operations & Maintenance (O&M).
- Place of Performance: JBSA Lackland, Texas.
Set-Aside
This is a sole-source acquisition and is not subject to set-aside requirements.
Evaluation & Justification
The Grifols Procleix Panther system is justified as the only source meeting all requirements, specifically due to its compact footprint (238 sq ft) and compatibility with existing Government-owned equipment, which avoids significant cost duplication and mission delays. Alternative systems were evaluated and rejected due to space limitations, utility incompatibility, or inability to perform the full panel of required assays. A previous "Notice of Intent to Sole Source" was published on SAM.gov, yielding zero interested parties. Future competition is planned by synchronizing this contract with a reagent procurement vehicle and conducting market research (RFI, Industry Day).
Contact Information
- Primary Contact: Matthew Brinkmann (matthew.j.brinkmann.civ@health.mil)
- Secondary Contact: Joe Wells (joe.d.wells3.civ@health.mil)